BackKrishna Institute of Medical Sciences Limited Overview

Krishna Institute of Medical Sciences Limited Total Liabilities

Track Krishna Institute of Medical Sciences Limited's total liabilities ($47B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$46.60B
↑ 15.08% YoYΔ $6.11B vs prior year quarter

Peer trimmed avg / median

Loading

Krishna Institute of Medical Sciences Limited Total Liabilities History

Loading

Krishna Institute of Medical Sciences Limited vs. peers: Total Liabilities Comparison

Loading

Krishna Institute of Medical Sciences Limited Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Krishna Institute of Medical Sciences Limited (KIMS.NS) FAQ

Krishna Institute of Medical Sciences Limited (KIMS.NS) currently reports a total liabilities of $47B as of September 2026. That compares with $40B in the prior-year period — up 15.1% year over year. Use the charts on this page to explore Krishna Institute of Medical Sciences Limited's total liabilities history and peer comparisons.

Krishna Institute of Medical Sciences Limited's total liabilities increased from $40B to $47B — a 15.1% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Krishna Institute of Medical Sciences Limited reported $47B in total liabilities as of September 2026. That compares with $40B in the prior-year period — up 15.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $47B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Krishna Institute of Medical Sciences Limited, and consider following KIMS.NS for alerts when major investors trade the stock.